In our ever-more patient-centric world, a key question arises – what do patients think about direct-to-consumer (DTC) advertising? We partnered with eyeforpharma to answer this question in today’s changing environment. The FDA allowed us to reuse and update the patient portion of an FDA study conducted in 1999 and 2002, looking at patient and physician attitudes toward DTC.
We then conducted a survey of patient attitudes, results from which are published for the first time in this white paper.
The DTC Attitudes, Behaviors and Preferences survey takes its protocol from the earlier study and uses the FDA survey as a baseline, tracking how patient perspectives have evolved across nearly two decades.
Eyeforpharma also spoke to senior thought leaders in the pharmaceutical industry to gain feedback on these patient insights and to ask how companies are adapting to the evolution of engaged patients.